
zzso is generally expected to allow an escalation of total dose, thereby increasing zzso control rate, without increasing the risk of late zzso The purpose of this review is to assess the empirical evidence for this therapeutic gain from zzso zzso Although extensive clinical data have been accumulated until now, especially on treatment of head and neck cancer, the line of evidence is not zzso The present analysis indicates that the dose per fraction generally used in standard zzso is already a good zzso 

